Enter Note Done
Go to previous page in this tab
Session
  • Presentation | Poster - [In-Person Posters Sun] Drug Development: Human
  • Poster
  • Screening And Baseline Characteristics Of A Ph2b/3 Randomized, Placebo-Controlled Trial Of Emestedastat In Mild/Moderate AD [Board No. Sunday-0175]
  • Board no. Sunday-0175
    Set Timezone

Jack Taylor1, Paul Rolan2,1, Mark Jaros3, XanaMIA trial Investigators, Christopher Chen4, Dana Hilt1;
1Actinogen Medical, Sydney, Australia, 2University of Adelaide, Medical School, Adelaide, Australia, 3Summit Analytical, Denver, CO, USA, 4National University of Singapore, Singapore, Singapore
Types
Main Session